US Stock MarketDetailed Quotes

NARI Inari Medical

Watchlist
  • 41.600
  • +4.260+11.41%
Close May 1 16:00 ET
  • 41.530
  • -0.070-0.17%
Post 19:04 ET
2.41BMarket Cap-1386666P/E (TTM)

Inari Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-510.43%-12.29M
357.14%35.93M
8.76%12.24M
221.99%15.94M
418.85%9.76M
77.88%-2.01M
-154.82%-13.97M
-25.00%11.26M
-133.78%-13.07M
-141.92%-3.06M
Net income from continuing operations
-991.16%-24.2M
94.41%-1.64M
19.54%-4.67M
131.14%3.16M
120.47%2.09M
29.11%-2.22M
-397.43%-29.27M
-623.76%-5.8M
-262.09%-10.15M
-350.42%-10.19M
Operating gains losses
-69.23%8K
-3,720.21%-3.4M
-4,929.58%-3.43M
---4K
--4K
--26K
36.23%94K
--71K
----
----
Depreciation and amortization
55.26%4.62M
50.79%10.74M
82.54%3.45M
24.54%2.17M
17.71%2.14M
78.34%2.97M
65.25%7.12M
13.65%1.89M
74.40%1.74M
111.64%1.82M
Deferred tax
----
---584K
----
----
----
----
--0
----
----
----
Other non cash items
78,962.50%6.33M
-67.13%47K
-51.43%17K
-72.22%10K
-66.67%12K
-77.78%8K
0.00%143K
0.00%35K
12.50%36K
-10.00%36K
Change In working capital
-20.48%-11.35M
112.29%2.64M
35.04%9.54M
124.48%3.02M
73.18%-504K
34.15%-9.42M
-50.13%-21.47M
-7.32%7.07M
24.33%-12.35M
10.86%-1.88M
-Change in receivables
-406.76%-8.67M
35.09%-11.05M
110.64%512K
-33.17%-7.01M
-73.22%-7.39M
204.90%2.83M
-18.59%-17.03M
-38.90%-4.81M
29.19%-5.26M
-12,824.24%-4.27M
-Change in inventory
45.36%-2.09M
36.36%-7.44M
112.04%359K
51.72%-1.46M
13.12%-2.51M
-37.20%-3.83M
-11.44%-11.69M
-90.66%-2.98M
-116.27%-3.03M
35.10%-2.89M
-Change in prepaid assets
-1,458.70%-625K
381.00%10.28M
170.49%6.44M
195.15%3.94M
91.93%-152K
428.57%46K
79.88%-3.66M
240.45%2.38M
20.07%-4.14M
77.58%-1.88M
-Change in payables and accrued expense
106.66%540K
3.01%12.19M
-80.26%2.53M
7,286.92%7.9M
75.84%9.85M
-20.70%-8.1M
-59.90%11.83M
-11.76%12.83M
105.07%107K
-48.89%5.6M
-Change in other current liabilities
-37.98%-505K
-44.75%-1.34M
14.80%-305K
-1,595.24%-356K
-119.90%-309K
82.55%-366K
-19.56%-923K
-80.81%-358K
89.12%-21K
913.09%1.55M
Cash from discontinued investing activities
Operating cash flow
-510.43%-12.29M
357.14%35.93M
8.76%12.24M
221.99%15.94M
418.85%9.76M
77.88%-2.01M
-154.82%-13.97M
-25.00%11.26M
-133.78%-13.07M
-141.92%-3.06M
Investing cash flow
Cash flow from continuing investing activities
1,068.64%39.16M
70.28%-58.02M
-79.61%-59.72M
-11.80%11.82M
94.03%-6.08M
94.50%-4.04M
-282.61%-195.22M
-1,151.30%-33.25M
280.43%13.4M
-452.81%-101.86M
Capital expenditure reported
---660K
---1.49M
----
----
----
--0
--0
----
----
----
Net PPE purchase and sale
-29.67%-1.25M
52.67%-4.71M
48.88%-909K
30.36%-1.61M
60.60%-1.23M
64.88%-964K
27.07%-9.95M
34.58%-1.78M
51.30%-2.31M
36.62%-3.12M
Net business purchase and sale
----
---240.42M
----
----
----
----
--0
----
----
----
Net investment purchase and sale
1,433.94%41.07M
201.80%188.6M
681.85%183.1M
-14.52%13.43M
95.09%-4.85M
95.65%-3.08M
-395.67%-185.27M
-51,688.52%-31.47M
684.70%15.71M
-631.14%-98.74M
Cash from discontinued investing activities
Investing cash flow
1,068.64%39.16M
70.28%-58.02M
-79.61%-59.72M
-11.80%11.82M
94.03%-6.08M
94.50%-4.04M
-282.61%-195.22M
-1,151.30%-33.25M
280.43%13.4M
-452.81%-101.86M
Financing cash flow
Cash flow from continuing financing activities
-58.84%1.02M
-99.34%1.17M
-42.69%-2.41M
-10.64%3.47M
-47.46%-2.35M
-98.60%2.47M
4,249.08%177.14M
-172.42%-1.69M
29.64%3.88M
-210.31%-1.6M
Net common stock issuance
-4.53%3.98M
-94.57%9.92M
0.00%1K
15.08%5.75M
--0
-97.65%4.17M
3,189.26%182.82M
--1K
35.88%5M
--0
Proceeds from stock option exercised by employees
-35.84%145K
1.73%824K
38.50%277K
-1.83%107K
37.18%214K
-34.49%226K
-6.79%810K
45.99%200K
-31.45%109K
-18.75%156K
Net other financing activities
-61.13%-3.11M
-47.54%-9.57M
-42.22%-2.69M
-95.10%-2.39M
-46.54%-2.57M
-18.97%-1.93M
-175.66%-6.49M
-149.67%-1.89M
-45.37%-1.22M
-148.02%-1.75M
Cash from discontinued financing activities
Financing cash flow
-58.84%1.02M
-99.34%1.17M
-42.69%-2.41M
-10.64%3.47M
-47.46%-2.35M
-98.60%2.47M
4,249.08%177.14M
-172.42%-1.69M
29.64%3.88M
-210.31%-1.6M
Net cash flow
Beginning cash position
-34.89%39.21M
-35.07%60.22M
6.77%89.18M
-27.45%57.84M
-69.68%56.56M
-35.07%60.22M
-19.08%92.75M
2.92%83.53M
-12.70%79.72M
81.29%186.56M
Current changes in cash
876.85%27.89M
34.73%-20.92M
-110.65%-49.89M
640.68%31.23M
101.25%1.33M
-103.82%-3.59M
-49.33%-32.05M
-301.88%-23.68M
142.06%4.22M
-815.24%-106.52M
Effect of exchange rate changes
257.14%110K
80.42%-94K
-123.73%-89K
128.64%118K
83.23%-53K
44.88%-70K
-19.40%-480K
375.74%375K
-194.29%-412K
-654.39%-316K
End cash Position
18.82%67.21M
-34.89%39.21M
-34.89%39.21M
6.77%89.18M
-27.45%57.84M
-69.68%56.56M
-35.07%60.22M
-35.07%60.22M
2.92%83.53M
-12.70%79.72M
Free cash flow
-376.92%-14.2M
224.26%29.73M
3.84%9.84M
193.21%14.33M
238.04%8.53M
74.87%-2.98M
-302.04%-23.92M
-22.88%9.48M
-48.84%-15.38M
-359.55%-6.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -510.43%-12.29M357.14%35.93M8.76%12.24M221.99%15.94M418.85%9.76M77.88%-2.01M-154.82%-13.97M-25.00%11.26M-133.78%-13.07M-141.92%-3.06M
Net income from continuing operations -991.16%-24.2M94.41%-1.64M19.54%-4.67M131.14%3.16M120.47%2.09M29.11%-2.22M-397.43%-29.27M-623.76%-5.8M-262.09%-10.15M-350.42%-10.19M
Operating gains losses -69.23%8K-3,720.21%-3.4M-4,929.58%-3.43M---4K--4K--26K36.23%94K--71K--------
Depreciation and amortization 55.26%4.62M50.79%10.74M82.54%3.45M24.54%2.17M17.71%2.14M78.34%2.97M65.25%7.12M13.65%1.89M74.40%1.74M111.64%1.82M
Deferred tax -------584K------------------0------------
Other non cash items 78,962.50%6.33M-67.13%47K-51.43%17K-72.22%10K-66.67%12K-77.78%8K0.00%143K0.00%35K12.50%36K-10.00%36K
Change In working capital -20.48%-11.35M112.29%2.64M35.04%9.54M124.48%3.02M73.18%-504K34.15%-9.42M-50.13%-21.47M-7.32%7.07M24.33%-12.35M10.86%-1.88M
-Change in receivables -406.76%-8.67M35.09%-11.05M110.64%512K-33.17%-7.01M-73.22%-7.39M204.90%2.83M-18.59%-17.03M-38.90%-4.81M29.19%-5.26M-12,824.24%-4.27M
-Change in inventory 45.36%-2.09M36.36%-7.44M112.04%359K51.72%-1.46M13.12%-2.51M-37.20%-3.83M-11.44%-11.69M-90.66%-2.98M-116.27%-3.03M35.10%-2.89M
-Change in prepaid assets -1,458.70%-625K381.00%10.28M170.49%6.44M195.15%3.94M91.93%-152K428.57%46K79.88%-3.66M240.45%2.38M20.07%-4.14M77.58%-1.88M
-Change in payables and accrued expense 106.66%540K3.01%12.19M-80.26%2.53M7,286.92%7.9M75.84%9.85M-20.70%-8.1M-59.90%11.83M-11.76%12.83M105.07%107K-48.89%5.6M
-Change in other current liabilities -37.98%-505K-44.75%-1.34M14.80%-305K-1,595.24%-356K-119.90%-309K82.55%-366K-19.56%-923K-80.81%-358K89.12%-21K913.09%1.55M
Cash from discontinued investing activities
Operating cash flow -510.43%-12.29M357.14%35.93M8.76%12.24M221.99%15.94M418.85%9.76M77.88%-2.01M-154.82%-13.97M-25.00%11.26M-133.78%-13.07M-141.92%-3.06M
Investing cash flow
Cash flow from continuing investing activities 1,068.64%39.16M70.28%-58.02M-79.61%-59.72M-11.80%11.82M94.03%-6.08M94.50%-4.04M-282.61%-195.22M-1,151.30%-33.25M280.43%13.4M-452.81%-101.86M
Capital expenditure reported ---660K---1.49M--------------0--0------------
Net PPE purchase and sale -29.67%-1.25M52.67%-4.71M48.88%-909K30.36%-1.61M60.60%-1.23M64.88%-964K27.07%-9.95M34.58%-1.78M51.30%-2.31M36.62%-3.12M
Net business purchase and sale -------240.42M------------------0------------
Net investment purchase and sale 1,433.94%41.07M201.80%188.6M681.85%183.1M-14.52%13.43M95.09%-4.85M95.65%-3.08M-395.67%-185.27M-51,688.52%-31.47M684.70%15.71M-631.14%-98.74M
Cash from discontinued investing activities
Investing cash flow 1,068.64%39.16M70.28%-58.02M-79.61%-59.72M-11.80%11.82M94.03%-6.08M94.50%-4.04M-282.61%-195.22M-1,151.30%-33.25M280.43%13.4M-452.81%-101.86M
Financing cash flow
Cash flow from continuing financing activities -58.84%1.02M-99.34%1.17M-42.69%-2.41M-10.64%3.47M-47.46%-2.35M-98.60%2.47M4,249.08%177.14M-172.42%-1.69M29.64%3.88M-210.31%-1.6M
Net common stock issuance -4.53%3.98M-94.57%9.92M0.00%1K15.08%5.75M--0-97.65%4.17M3,189.26%182.82M--1K35.88%5M--0
Proceeds from stock option exercised by employees -35.84%145K1.73%824K38.50%277K-1.83%107K37.18%214K-34.49%226K-6.79%810K45.99%200K-31.45%109K-18.75%156K
Net other financing activities -61.13%-3.11M-47.54%-9.57M-42.22%-2.69M-95.10%-2.39M-46.54%-2.57M-18.97%-1.93M-175.66%-6.49M-149.67%-1.89M-45.37%-1.22M-148.02%-1.75M
Cash from discontinued financing activities
Financing cash flow -58.84%1.02M-99.34%1.17M-42.69%-2.41M-10.64%3.47M-47.46%-2.35M-98.60%2.47M4,249.08%177.14M-172.42%-1.69M29.64%3.88M-210.31%-1.6M
Net cash flow
Beginning cash position -34.89%39.21M-35.07%60.22M6.77%89.18M-27.45%57.84M-69.68%56.56M-35.07%60.22M-19.08%92.75M2.92%83.53M-12.70%79.72M81.29%186.56M
Current changes in cash 876.85%27.89M34.73%-20.92M-110.65%-49.89M640.68%31.23M101.25%1.33M-103.82%-3.59M-49.33%-32.05M-301.88%-23.68M142.06%4.22M-815.24%-106.52M
Effect of exchange rate changes 257.14%110K80.42%-94K-123.73%-89K128.64%118K83.23%-53K44.88%-70K-19.40%-480K375.74%375K-194.29%-412K-654.39%-316K
End cash Position 18.82%67.21M-34.89%39.21M-34.89%39.21M6.77%89.18M-27.45%57.84M-69.68%56.56M-35.07%60.22M-35.07%60.22M2.92%83.53M-12.70%79.72M
Free cash flow -376.92%-14.2M224.26%29.73M3.84%9.84M193.21%14.33M238.04%8.53M74.87%-2.98M-302.04%-23.92M-22.88%9.48M-48.84%-15.38M-359.55%-6.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg